These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8392976)

  • 1. TnphoA-mediated disruption of K54 capsular polysaccharide genes in Escherichia coli confers serum sensitivity.
    Russo TA; Moffitt MC; Hammer CH; Frank MM
    Infect Immun; 1993 Aug; 61(8):3578-82. PubMed ID: 8392976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An extraintestinal, pathogenic isolate of Escherichia coli (O4/K54/H5) can produce a group 1 capsule which is divergently regulated from its constitutively produced group 2, K54 capsular polysaccharide.
    Russo TA; Singh G
    J Bacteriol; 1993 Dec; 175(23):7617-23. PubMed ID: 8244930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of K54 capsular polysaccharide increases the pathogenicity of Escherichia coli in vivo.
    Russo TA; Liang Y; Cross AS
    J Infect Dis; 1994 Jan; 169(1):112-8. PubMed ID: 8277173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification, genomic organization, and analysis of the group III capsular polysaccharide genes kpsD, kpsM, kpsT, and kpsE from an extraintestinal isolate of Escherichia coli (CP9, O4/K54/H5).
    Russo TA; Wenderoth S; Carlino UB; Merrick JM; Lesse AJ
    J Bacteriol; 1998 Jan; 180(2):338-49. PubMed ID: 9440523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of isogenic K54 capsule-deficient Escherichia coli strains through TnphoA-mediated gene disruption.
    Russo TA; Guenther JE; Wenderoth S; Frank MM
    Mol Microbiol; 1993 Jul; 9(2):357-64. PubMed ID: 8412686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The construction and characterization of colanic acid deficient mutants in an extraintestinal isolate of Escherichia coli (O4/K54/H5).
    Russo TA; Sharma G; Weiss J; Brown C
    Microb Pathog; 1995 Apr; 18(4):269-78. PubMed ID: 7476092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of the O4 antigen moiety from the lipopolysaccharide of an extraintestinal isolate of Escherichia coli has only minor effects on serum sensitivity and virulence in vivo.
    Russo TA; Sharma G; Brown CR; Campagnari AA
    Infect Immun; 1995 Apr; 63(4):1263-9. PubMed ID: 7890383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of capsular polysaccharide determines serum resistance in Escherichia coli K92.
    Suerbaum S; Friedrich S; Leying H; Opferkuch W
    Zentralbl Bakteriol; 1994 Aug; 281(2):146-57. PubMed ID: 7858342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-Wide Discovery of Genes Required for Capsule Production by Uropathogenic
    Goh KGK; Phan MD; Forde BM; Chong TM; Yin WF; Chan KG; Ulett GC; Sweet MJ; Beatson SA; Schembri MA
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of K1-encapsulated Escherichia coli to killing by the bactericidal/permeability-increasing protein of rabbit and human neutrophils.
    Weiss J; Victor M; Cross AS; Elsbach P
    Infect Immun; 1982 Dec; 38(3):1149-53. PubMed ID: 6759406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis.
    Vogel U; Weinberger A; Frank R; Müller A; Köhl J; Atkinson JP; Frosch M
    Infect Immun; 1997 Oct; 65(10):4022-9. PubMed ID: 9317002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptidoglycan Association of Murein Lipoprotein Is Required for KpsD-Dependent Group 2 Capsular Polysaccharide Expression and Serum Resistance in a Uropathogenic
    Diao J; Bouwman C; Yan D; Kang J; Katakam AK; Liu P; Pantua H; Abbas AR; Nickerson NN; Austin C; Reichelt M; Sandoval W; Xu M; Whitfield C; Kapadia SB
    mBio; 2017 May; 8(3):. PubMed ID: 28536290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capsular polysaccharide and O-specific antigen divergently modulate pulmonary neutrophil influx in an Escherichia coli model of gram-negative pneumonitis in rats.
    Russo TA; Davidson BA; Priore RL; Carlino UB; Helinski JD; Knight PR
    Infect Immun; 2000 May; 68(5):2854-62. PubMed ID: 10768982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The O4 specific antigen moiety of lipopolysaccharide but not the K54 group 2 capsule is important for urovirulence of an extraintestinal isolate of Escherichia coli.
    Russo T; Brown JJ; Jodush ST; Johnson JR
    Infect Immun; 1996 Jun; 64(6):2343-8. PubMed ID: 8675348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of growth temperature of Escherichia coli on K1 capsular antigen production and resistance to opsonization.
    Bortolussi R; Ferrieri P; Quie PG
    Infect Immun; 1983 Mar; 39(3):1136-41. PubMed ID: 6341228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-capsular antibodies activate killing of Escherichia coli O8:K87 by the alternate complement pathway in porcine serum.
    Clark NM; Berberov EM; Wang M; Moxley RA
    Vet Immunol Immunopathol; 2006 Nov; 114(1-2):185-91. PubMed ID: 16919781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a polysaccharide capsular antigen of septicemic Escherichia coli O115:K "V165" :F165 and evaluation of its role in pathogenicity.
    Ngeleka M; Harel J; Jacques M; Fairbrother JM
    Infect Immun; 1992 Dec; 60(12):5048-56. PubMed ID: 1452337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to complement-mediated killing.
    Pluschke G; Mayden J; Achtman M; Levine RP
    Infect Immun; 1983 Dec; 42(3):907-13. PubMed ID: 6196296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.